CMBA
INSP icon

C.M. Bidwell & Associates’s Inspire Medical Systems INSP Stock Holding History

C.M. Bidwell & Associates’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-796
Closed -$258K – 555
2023
Q2 		$258K Sell
796
-19
-2% -$5.43K 0.19% 91
2023
Q1 		$191K Sell
815
-47
-5% -$11.9K 0.14% 123
2022
Q4 		$217K Hold
862
– – 0.17% 117
2022
Q3 		$153K Buy
862
+2
+0.2% +$402 0.13% 145
2022
Q2 		$157K Hold
860
– – 0.12% 154
2022
Q1 		$221K Hold
860
– – 0.14% 136
2021
Q4 		$198K Buy
+860
New +$210K 0.12% 166

Other funds holding INSP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

C.M. Bidwell & Associates's INSP Position: Q3 2023 in Review

C.M. Bidwell & Associates sold out of Inspire Medical Systems (INSP) in Q3 2023, closing a stake of 796 shares — an estimated $258K sold.

C.M. Bidwell & Associates first reported a position in INSP in Q4 2021 and held it in 7 quarters. The position peaked at $258K in Q2 2023. 364 funds tracked by Wall St. Rank hold INSP as of Q3 2023.

  • C.M. Bidwell & Associates reported no remaining Inspire Medical Systems position as of Q3 2023 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 796 Inspire Medical Systems shares in Q3 2023, an estimated $258K.
  • C.M. Bidwell & Associates first reported a position in Inspire Medical Systems in Q4 2021 and held it in 7 quarters.
  • C.M. Bidwell & Associates's Inspire Medical Systems position peaked at $258K in Q2 2023.
  • 364 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2023.

Based on C.M. Bidwell & Associates's 13F filing for Q3 2023, filed 13 Nov 2023.